Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk.

Öztürk, A B; Çaglayan, B

Öztürk, A B; Çaglayan, B.

Öztürk AB; Division of Allergy and Immunology, Department of Pulmonary Medicine, School of Medicine, Koç University, Istanbul, Turkey.
Çaglayan B; Department of Pulmonary Medicine, School of Medicine, Koç University, Istanbul, Turkey.

Eur Ann Allergy Clin Immunol ; 52(6): 282-285, 2020 11.

Article in English | MEDLINE | ID: covidwho-761270

Subject(s)

Asthma/pathology; Coronavirus Infections/pathology; Peptidyl-Dipeptidase A/metabolism; Pneumonia, Viral/pathology; Receptors, Virus/metabolism; Angiotensin-Converting Enzyme 2; Asthma/complications; Betacoronavirus; COVID-19; Comorbidity; Coronavirus Infections/complications; Humans; Pandemics; Peptidyl-Dipeptidase A/genetics; Pneumonia, Viral/complications; Receptors, Virus/genetics; Risk Factors; SARS-CoV-2; Serine Endopeptidases/metabolism

Keywords

ACE2; COVID-19; SARS-CoV-2; TMPRSS2; asthma; infection; severe asthma

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Receptors, Virus / Asthma / Coronavirus Infections / Peptidyl-Dipeptidase A Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Eur Ann Allergy Clin Immunol Journal subject: Allergy and Immunology Year: 2020 Document Type: Article Affiliation country: EurAnnACI.1764-1489.169

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google